Vascular Risk Factors for Incident Alzheimer Disease and Vascular Dementia

Hofman, 1997, Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study, Lancet, 349, 151, 10.1016/S0140-6736(96)09328-2

Chandra, 1998, Gene-environment interaction in Alzheimer's disease: a potential role for cholesterol, Neuroepidemiology, 17, 225, 10.1159/000026175

Romas, 1999, APOE genotype, plasma lipids, lipoproteins, and AD in community elderly, Neurology, 53, 517, 10.1212/WNL.53.3.517

Kivipelto, 2001, Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study, BMJ, 322, 1447, 10.1136/bmj.322.7300.1447

Notkola, 1998, Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease, Neuroepidemiology, 17, 14, 10.1159/000026149

Puglielli, 2003, Alzheimer's disease: the cholesterol connection, Nat Neurosci, 6, 345, 10.1038/nn0403-345

Sparks, 2000, Link between heart disease, cholesterol, and Alzheimer's disease: a review, Microsc Res Tech, 50, 287, 10.1002/1097-0029(20000815)50:4<287::AID-JEMT7>3.0.CO;2-L

Kivipelto, 2002, Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease, Ann Intern Med, 137, 149, 10.7326/0003-4819-137-3-200208060-00006

Skoog, 1996, 15-year longitudinal study of blood pressure and dementia, Lancet, 347, 1141, 10.1016/S0140-6736(96)90608-X

Launer, 2000, Midlife blood pressure and dementia: the Honolulu-Asia aging study, Neurobiol Aging, 21, 49, 10.1016/S0197-4580(00)00096-8

Gustafson, 2003, An 18-year follow-up of overweight and risk of Alzheimer disease, Arch Intern Med, 163, 1524, 10.1001/archinte.163.13.1524

Guo, 1996, Low blood pressure and dementia in elderly people: the Kungsholmen project, BMJ, 312, 805, 10.1136/bmj.312.7034.805

Skoog, 1998, A population study on blood-brain barrier function in 85-year-olds: relation to Alzheimer's disease and vascular dementia, Neurology, 50, 966, 10.1212/WNL.50.4.966

Peila, 2002, Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu-Asia Aging Study, Diabetes, 51, 1256, 10.2337/diabetes.51.4.1256

Newman, 2001, Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery, N Engl J Med, 344, 395, 10.1056/NEJM200102083440601

Selnes, 2001, Cognitive changes 5 years after coronary artery bypass grafting: is there evidence of late decline?, Arch Neurol, 58, 598, 10.1001/archneur.58.4.598

Honig, 2003, Stroke and the risk of Alzheimer Disease, Arch Neurol, 60, 1707, 10.1001/archneur.60.12.1707

Snowdon, 1997, Brain infarction and the clinical expression of Alzheimer disease. The Nun Study, JAMA, 277, 813, 10.1001/jama.1997.03540340047031

Miech, 2002, Incidence of AD may decline in the early 90s for men, later for women: the Cache County Study, Neurology, 58, 209, 10.1212/WNL.58.2.209

Breitner, 1999, APOE-epsilon4 count predicts age when prevalence of AD increases, then declines: the Cache County Study, Neurology, 53, 321, 10.1212/WNL.53.2.321

Khachaturian, 2000, Performance characteristics of a two-stage dementia screen in a population sample, J Clin Epidemiol, 53, 531, 10.1016/S0895-4356(99)00196-1

Tschanz, 2002, An adaptation of the modified mini-mental state examination: analysis of demographic influences and normative data: the Cache County Study, Neuropsychiatry Neuropsychol Behav Neurol, 15, 28

Teng, 1987, The modified mini-mental state (3MS) examination, J Clin Psychiatry, 48, 314

Jorm, 1989, The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms, Psychol Med, 19, 1015, 10.1017/S0033291700005742

Silverman, 1986, Reliability of the family history method in genetic studies of Alzheimer's disease and related dementias, Am J Psychiatry, 143, 1279, 10.1176/ajp.143.10.1279

Cummings, 1994, The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia, Neurology, 44, 2308, 10.1212/WNL.44.12.2308

Clark, 1996, Performance of the dementia severity rating scale: a caregiver questionnaire for rating severity in Alzheimer disease, Alzheimer Dis Assoc Disord, 10, 31

Tschanz, 2000, Dementia diagnoses from clinical and neuropsychological data compared: the Cache County Study, Neurology, 54, 1290, 10.1212/WNL.54.6.1290

1987, Diagnostic and Statistical Manual of Mental Disorders. 3rd ed. Revised: DSM-III-R

McKhann, 1984, Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease, Neurology, 34, 939, 10.1212/WNL.34.7.939

Roman, 1993, Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop, Neurology, 43, 250, 10.1212/WNL.43.2.250

Hughes, 1982, A new clinical scale for the staging of dementia, Br J Psychiatry, 140, 566, 10.1192/bjp.140.6.566

Hayden, 2003, Characteristics of a two-stage screen for incident dementia, J Clin Epidemiol, 56, 1038, 10.1016/S0895-4356(03)00247-6

1999–2001, Version 8.0

Allison, 1995, SAS Institute. Survival Analysis Using the SAS System: A Practical Guide

Rothman, 1998, Modern Epidemiology. 2nd ed

Rothman, 2002, Epidemiology. An Introduction

Szklo, 2000, Epidemiology: Beyond the Basics

Khachaturian, 2004, Apolipoprotein E epsilon4 count affects age at onset of Alzheimer disease, but not lifetime susceptibility: the Cache County Study, Arch Gen Psychiatry, 61, 518, 10.1001/archpsyc.61.5.518

Qiu, 2003, Combined effects of APOE genotype, blood pressure, and antihypertensive drug use on incident AD, Neurology, 61, 655, 10.1212/WNL.61.5.655

Ruitenberg, 2001, Blood pressure and risk of dementia: results from the Rotterdam study and the Gothenburg H-70 study, Dementia Geriatr Cogn Dis, 12, 33, 10.1159/000051233

Tan, 2003, Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham study, Arch Intern Med, 163, 1053, 10.1001/archinte.163.9.1053

Reitz, 2004, Relation of plasma lipids to Alzheimer disease and vascular dementia, Arch Neurol, 61, 705, 10.1001/archneur.61.5.705

Mielke, 2005, High total cholesterol levels in late life associated with a reduced risk of dementia, Neurology, 64, 1689, 10.1212/01.WNL.0000161870.78572.A5

Luchsinger, 2001, Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort, Am J Epidemiol, 154, 635, 10.1093/aje/154.7.635

Webber, 2005, Estrogen bows to a new master: the role of gonadotropins in Alzheimer pathogenesis, Ann N Y Acad Sci, 1052, 201, 10.1196/annals.1347.020

Malacara, 2001, Gonadotropins at menopause: the influence of obesity, insulin resistance, and estrogens, Steroids, 66, 559, 10.1016/S0039-128X(00)00223-3

Peeters, 2003, Obesity in adulthood and its consequences for life expectancy: a life-table analysis, Ann Intern Med, 138, 24, 10.7326/0003-4819-138-1-200301070-00008

Calle, 1999, Body-mass index and mortality in a prospective cohort of U.S. adults, N Engl J Med, 341, 1097, 10.1056/NEJM199910073411501

Hayden, 2005, Apolipoprotein E genotype and mortality: findings from the Cache County Study, J Am Geriatr Soc, 53, 935, 10.1111/j.1532-5415.2005.53301.x

Martin, 2000, Validation of self-reported chronic conditions and health services in a managed care population, Am J Prev Med, 18, 215, 10.1016/S0749-3797(99)00158-0

Robinson, 1997, Estimating the burden of disease. Comparing administrative data and self-reports, Med Care, 35, 932, 10.1097/00005650-199709000-00006

Tschanz, 2004, Dementia: the leading predictor of death in a defined elderly population: the Cache County Study, Neurology, 62, 1156, 10.1212/01.WNL.0000118210.12660.C2